GERN FY 2012 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+11.1% YoY

Gross Profit

-$22M-829.4% margin

Operating Income

-$72M-2648.9% margin

Net Income

-$69M-2542.7% margin

EPS (Diluted)

$-0.54

Cash Flow

Operating Cash Flow

-$55M

Free Cash Flow

-$56M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$100M

Total Liabilities

$14M

Stockholders' Equity

$86M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$2M	+11.1%
Gross Profit	-$22M	$2M	-1021.6%
Operating Income	-$72M	-$96M	+25.3%
Net Income	-$69M	-$97M	+28.9%